Bonney R C, Franks S
Department of Chemical Pathology, St Mary's Hospital Medical School, London, UK.
Gynecol Endocrinol. 1988 Jun;2(2):131-8. doi: 10.3109/09513598809023621.
The activity of 2 phospholipase A2 enzymes, PLA2(i) and PLA2(ii) was measured in endometrium in women with regular menstrual cycles without evidence of pathology and in those complaining of menstrual disturbances. There was a significant 4-fold increase in PLA2(i) activity in secretory phase endometrium (mean +/- SD: 32.7 +/- 9.5 pmol per mg protein/minute) compared to that of the proliferative and menstrual phases (9.5 +/- 4.9 and 6.1 +/- 2.6 pmol per mg protein/minute, respectively) but PLA2(ii) activity was variable and not related to the stage of the cycle (range: 4.0-97.0, 18.7-110.3 and 0.1-85.5 pmol per mg protein/minute for proliferative, secretory and menstrual phases, respectively). There was no significant difference between normal subjects and those with menorrhagia with respect to the mean activities of either isoenzyme at any stage of the cycle. Women with polycystic ovary syndrome (PCO) had markedly higher endometrial PLA2(ii) activity than normal subjects. The evidence of this study suggests that PLA2(ii) is not implicated in unexplained menorrhagia, but our preliminary findings indicate that the high level of PLA2(ii) activity found in the endometrium of women with PCO might be a marker of abnormal endometrial function.
在月经周期规律且无病理证据的女性以及主诉月经紊乱的女性的子宫内膜中,测量了两种磷脂酶A2酶(PLA2(i)和PLA2(ii))的活性。与增殖期和月经期相比,分泌期子宫内膜中PLA2(i)活性显著增加了4倍(平均值±标准差:每毫克蛋白质每分钟32.7±9.5皮摩尔)(增殖期和月经期分别为每毫克蛋白质每分钟9.5±4.9和6.1±2.6皮摩尔),但PLA2(ii)活性变化不定,且与月经周期阶段无关(增殖期、分泌期和月经期的范围分别为每毫克蛋白质每分钟4.0 - 97.0、18.7 - 110.3和0.1 - 85.5皮摩尔)。在月经周期的任何阶段,正常受试者和月经过多患者的两种同工酶的平均活性之间均无显著差异。多囊卵巢综合征(PCO)女性的子宫内膜PLA2(ii)活性明显高于正常受试者。本研究证据表明,PLA2(ii)与不明原因的月经过多无关,但我们的初步研究结果表明,PCO女性子宫内膜中发现的高水平PLA2(ii)活性可能是子宫内膜功能异常的一个标志物。